Abstract
FMN adenylyltransferase (FMNAT) is an essential enzyme catalyzing the last step of a two-step pathway converting riboflavin (vitamin B2) to FAD, the ubiquitous flavocoenzyme. A structure-based mutagenesis and steady-state kinetic analysis of yeast FMNAT unexpectedly revealed that mutant D181A had a much faster turnover rate than the wild-type enzyme. Product inhibition analysis showed that wild-type FMNAT is strongly inhibited by FAD, whereas the D181A mutant has an attenuated product inhibition. These results provide a structural basis for the product inhibition of the enzyme and suggest that product release may be the rate-limiting step of the reaction.
Original language | English (US) |
---|---|
Pages (from-to) | 3615-3617 |
Number of pages | 3 |
Journal | Biochemistry |
Volume | 52 |
Issue number | 21 |
DOIs | |
State | Published - May 28 2013 |
ASJC Scopus subject areas
- Biochemistry